Mode
Text Size
Log in / Sign up

Elevated neutrophil-to-lymphocyte ratio correlates with greater cerebral small vessel disease burden and white matter hyperintensitiesHigh Neutrophil Levels Linked to Brain Small Vessel Damage

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that elevated NLR correlates with higher CSVD burden and white matter hyperintensities but not with microbleeds.

This systematic review and meta-analysis evaluated the relationship between neutrophil-to-lymphocyte ratio (NLR) and markers of cerebral small vessel disease (CSVD) in a large cohort of 62,961 patients. The analysis indicates that an elevated NLR is significantly associated with the presence of CSVD (OR 1.43; 95% CI 1.07-1.93) and a greater total CSVD burden (OR 1.55; 95% CI 1.11-2.18). Additionally, higher NLR was associated with severe white matter hyperintensities (OR 1.36; 95% CI 1.04-1.76) and increased white matter hyperintensity volume (beta=0.08; 95% CI 0.02-0.15).

Specific markers such as lacunes showed a positive association with elevated NLR (OR 1.26; 95% CI 1.16-1.36). Conversely, no significant association was found between NLR and microbleeds (OR 0.94; 95% CI 0.82-1.09). The authors noted that data regarding enlarged perivascular spaces were limited.

Clinical interpretation is tempered by substantial heterogeneity in CSVD and white matter hyperintensity data. While the findings suggest that NLR may reflect inflammatory pathways related to ischemic small vessel injury, the authors emphasize that these are associations only. Larger longitudinal studies are required to establish causal links or clinical relevance for managing patients with cerebral small vessel disease.

How this fits prior evidence

This meta-analysis addresses a gap in specific biomarker data for cerebral small vessel disease (CSVD) by identifying NLR as a potential indicator of inflammatory pathways related to ischemic injury. It extends the scope of previous evidence which noted that higher m-cSVD scores are linked to increased stroke risk in hemorrhage-prone patients and that inflammation is present in dementia subtypes, though causality remains undetermined.

Researchers analyzed data from over 62,000 patients to look at how certain blood markers relate to cerebral small vessel disease. This condition involves damage to the tiny blood vessels in the brain and is often linked to issues like stroke and vascular dementia.

The study found that a higher neutrophil-to-lymphocyte ratio (NLR) was associated with the presence of these vessel issues. Specifically, patients with higher NLR levels showed more significant markers of damage, including larger areas of white matter hyperintensities and more lacunes. These findings suggest that inflammation might play a role in how small blood vessels are injured.

It is important to note that this study shows a link between the blood marker and brain health, but it does not prove that one causes the other. Additionally, no link was found between this specific marker and microbleeds. Because this was an observational analysis of existing data, more long-term studies are needed to understand how these findings might change clinical care.

What this means for you:
Higher neutrophil levels are linked to more severe small vessel damage in the brain, potentially reflecting inflammation.

Common questions

What is the link between blood markers and brain health?

The study found that an elevated neutrophil-to-lymphocyte ratio (NLR) is linked to the presence of cerebral small vessel disease. Specifically, higher NLR was associated with a greater total burden of damage, including more severe white matter hyperintensities and larger lacunes in the brain.

Does this mean high neutrophil levels cause brain damage?

The study shows an association between these blood markers and vessel damage, but it does not prove that one causes the other. Researchers note that more long-term studies are needed to confirm if there is a direct causal link or clinical impact.

Were any specific types of brain damage not linked to this marker?

While several markers of small vessel disease showed a link to higher neutrophil levels, the study found no association between the neutrophil-to-lymphocyte ratio and microbleeds (CMBs). This means the marker did not appear related to those specific hemorrhagic indicators.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Background and objectivesCerebral small vessel disease (CSVD) causes about 25% of ischemic strokes, most intracerebral hemorrhages, and is a major cause of vascular dementia. The neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, has shown inconsistent associations with CSVD. We performed a meta-analysis to quantify the association between NLR and CSVD imaging markers.MethodsPubmed, Embase, and Cochrane Library were searched through August 10, 2025 for studies of NLR and CSVD. Fifteen studies (n = 62,961) were included. Outcomes included CSVD presence, total CSVD burden, and imaging subtypes (white matter hyperintensities [WMH], lacunes, microbleeds [CMBs], enlarged perivascular spaces [EPVS]).ResultsElevated NLR was associated with presence of CSVD (OR 1.43, 95% CI 1.07–1.93) and greater total CSVD burden (OR 1.55, 95% CI 1.11–2.18). NLR also had associations with WMH (severe WMH: OR 1.36, 95% CI 1.04–1.76; WMH volume: β=0.08, 95% CI 0.02–0.15) and lacunes (OR 1.26, 95% CI 1.16–1.36); it was not associated with CMBs (OR 0.94, 95% CI 0.82–1.09), and EPVS data were limited. Substantial heterogeneity was noted for CSVD and WMH but not for lacunes or CMBs. Removing one study resolved heterogeneity for total CSVD burden, and excluding a high-bias study eliminated the WMH severity association.ConclusionHigher NLR showed a limited but consistent association with ischemic CSVD markers, particularly WMH and lacunes, whereas no association was observed with hemorrhagic markers such as CMBs. NLR may therefore reflect inflammatory pathways more closely related to ischemic small vessel injury, but larger longitudinal studies are needed to confirm its causal and clinical relevance.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251125195, identifier: CRD420251125195.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.